Tokyo, Japan

Asana Makino

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 7.7

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Asana Makino: Innovator in Nucleic Acid Conjugates

Introduction

Asana Makino is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of nucleic acid research, holding a total of 3 patents. Her work focuses on developing innovative oligonucleotides with enhanced properties for therapeutic applications.

Latest Patents

Among her latest patents, one notable invention is a nucleic acid conjugate. This invention provides a nucleic acid conjugate in which a sugar chain ligand is bonded to an oligonucleotide via a linker. The sugar chain ligand features O-bonded mannose at its non-reducing end. Another significant patent involves an oligonucleotide that exhibits improved affinity for AGO2. This oligonucleotide has specific nucleotide residues that enhance its binding capabilities, which is crucial for its knockdown activity against mRNA encoding proteins involved in various diseases.

Career Highlights

Asana has worked with reputable companies such as Kyowa Hakko Kirin Co., Limited and Kyowa Kirin Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Throughout her career, Asana has collaborated with esteemed colleagues, including Fumikazu Shinohara and Junichiro Yamamoto. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Asana Makino's contributions to the field of nucleic acid research are noteworthy. Her innovative patents and collaborations highlight her role as a leading inventor in this important area of study.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…